Search results

Restoring soil carbon can bring benefits for agricultural productivity and climate change mitigation.

Health researchers at ANSTO use world-class nuclear and isotopic techniques to undertake research and development activities to address some of the most challenging health problems.

An investment that will secure the long term sustainability of nuclear medicine supply in Australia.

Timetable and Teams links

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.

ANSTO has contributed to research on a novel therapeutic option for combatting antimicrobial-resistant Gram-negative bacteria, known as superbugs.

Australia has one multi-purpose nuclear reactor, the Open Pool Light Water Reactor (OPAL) and it is not used to generate ‘nuclear power’.

New screening method developed to confirm if deuteration improves metabolic stability.

ANSTO expertise focused on understanding of reduced water levels at Thirlmere Lakes in three year collaborative project

An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.

See details of previously published customer updates from our Health products team. 

Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.